Webinars and Sponsored Roundtables — Register Now
Tuesday, July 21, 2026, 11:00-11:30 AM CT
- Explain how transparency and manufacturer partnerships improve quality, consistency, and decision-making confidence in specimen management.
- Evaluate blood collection tubes beyond cost and commodity assumptions, incorporating clinical impact and risk into decision-making.
- Assess the potential risk points when using a blood collection device that has not been cleared for a specific purpose.
Roundtable presenters Nick Fingland, PhD, PMP, Senior Director, R&D Operations and Science, BD, and Chris Farnsworth, PhD, D(ABCC), Section Head of Clinical Chemistry, Professor of Pathology and Immunology, Washington University School of Medicine.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, July 29, 2026, 1:00-2:00 PM ET
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.
Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Interactive Product Guides
Product Spotlight
Scopio Labs
X100/X100HT with Full-Field Peripheral Blood Smear Application
| Company | Scopio Labs |
|---|---|
| Name of analyzer | X100/X100HT with Full-Field Peripheral Blood Smear Application |
| Contact | Lianne Trantz |
| City, State | Tel Aviv, Israel |
| Website | |
| Analyzer application | diagnostic and research use |
| Dimensions of analyzer (H × W × | 37.5 × 36.2 × 32 in./— |
| Country where analyzer was | Israel/Israel |
| First year analyzer was sold in U.S./Approximate No. of units installed in U.S.* | 2022/— |
| First year analyzer sold outside | 2022/— |
| Foreign locations where company | Canada, U.K., Ireland, Europe, Israel (installed in Canada, U.K., Europe, Israel) |
| Human languages (other than | — |
| Analyzer list price | — (slide maker stainer sold separately) |
| • Analyzer acquisition options | purchase, lease |
| Training included with purchase/Total time for basic training per operator | — |
| • Follow-up training available | yes (extra charge) |
| Parameters that analyzer tests and reports | %&# eosinophils, %&# immature granulocytes, %&# lymphocytes, %&# monocytes, %&# neutrophils, %&# basophils, %&# reticulocyte count, PLT, RBC, NRBC, WBC |
| Types of testing FDA cleared or approved for analyzer | — |
| Types of body fluids FDA cleared or approved for analysis on analyzer | — |
| Analytical measurement range for body fluid | — |
| Precision for body fluid | — |
| Accuracy for body fluid | — |
| Automated differential performed for body fluids | — |
| Tests available for research use only | — |
| Differential methods used | — |
| Analytical measurement range: • WBC count/RBC count | — |
| Precision: • WBC count/RBC count | — |
| Accuracy: • WBC count/RBC count | — |
| Interfering substances: • WBC/RBC | — |
| • Hemoglobin/Platelets | — |
| • Hematocrit/Reticulocytes | — |
| • Automated differential | — |
| Throughput: max. CBCs per hour/Max. CBCs with differentials per hour | — |
| • Max. No. of slides processed per hour if stainer included | — |
| FDA-cleared or -approved sample container types (besides potassium EDTA) | — |
| Min. specimen volume open mode/Closed mode/Microsample capability | — |
| Types of patient data archived/Max. No. of archived patient data accessible when analyzer online | none/— |
| Analyzer performs delta checks | — |
| Parameters for which flags may appear | customizable to lab procedures and clinical findings (e.g. presence of plasma cells) |
| Analyzer recognizes and holds test results | yes, for potential test rerun (parameters for flags to hold samples defined by vendor) |
| Scattergram display uses cell-specific color | — |
| Histogram display uses color with thresholds | — |
| LIS interface formats supported | HL7 version 2, HL7 version 3 |
| • Middleware interface | yes (can use Remisol, ADM, Data Innovations) |
| • Information transferred to LIS via middleware or LIS interface | numeric results, flagged results, patient demographics, host query for patient demographics and orders |
| Analyzer transmits LOINC codes for results to LIS or middleware | yes (also provides list of machine codes for each test and corresponding LOINC code) |
| Lab automation system or workcells to which analyzer has a direct interface | available but not operational (to Beckman Coulter) |
| Barcode symbologies read on specimen tube | — |
| • Analyzer allows barcode placement per CLSI standard Auto02-A2 | — |
| No. of onboard reagents required for standard specimen analysis | — |
| • Reagents ready to use/Reagent tracking method | — |
| Onboard diagnostics for troubleshooting | — |
| • Manufacturer can perform diagnostics via remote access | yes |
| Warranty provided/Cost of annual service contract (24 h/7 d) | — |
| Notes | †also marketed by Beckman Coulter, Siemens Healthineers |